Co-administration of iloprost and eptifibatide in septic shock (CO-ILEPSS)—a randomised, controlled, double-blind investigator-initiated trial investigating safety and efficacy

BACKGROUND: Part of the pathophysiology in septic shock is a progressive activation of the endothelium and platelets leading to widespread microvascular injury with capillary leakage, microthrombi and consumption coagulopathy. Modulating the inflammatory response of endothelium and thrombocytes migh...

Descripción completa

Detalles Bibliográficos
Autores principales: Berthelsen, Rasmus Ehrenfried, Ostrowski, Sisse Rye, Bestle, Morten Heiberg, Johansson, Per Ingemar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6727583/
https://www.ncbi.nlm.nih.gov/pubmed/31488213
http://dx.doi.org/10.1186/s13054-019-2573-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6727583/
https://www.ncbi.nlm.nih.gov/pubmed/31488213
http://dx.doi.org/10.1186/s13054-019-2573-8

Ejemplares similares